Hyperbaric Oxygen Treatment on a Parkinson’s Disease Patient: A Case Study

Hoggard ML, Johnson KE and Shirachi DY. Chico Hyperbaric Center, Chico, CA 95926 and Department of Physiology and Pharmacology, T. J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95207, USA. INTRODUCTION Parkinson’s Disease (PD) is a chronic neurodegenerative disorder, which is characterized by the loss of dopaminergic neurons whose cell bodies are located in the substantia nigra […]

Continue reading »

One-Two Punch: Glutathione and HBOT

By Julian Whitaker, MD Parkinson’s disease is caused by the degeneration of neurons in the area of the brain that manufactures dopamine, a neurotransmitter that affects movement. As dopamine production drops, characteristic tremors and speech, balance, and motor problems develop. The primary treatment for Parkinson’s is drugs that replace or mimic dopamine, and though these meds improve symptoms, they do not slow disease […]

Continue reading »